Treatment of advanced ovarian cancer

This publication has 23 references indexed in Scilit:

• Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with platinum
  European Journal Of Cancer, 1997
• Activity of Gemcitabine in Patients with Advanced Ovarian Cancer: Responses Seen Following Platinum and Paclitaxel
  Gynecologic Oncology, 1996
• Twelve-year follow-up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer
  International Journal of Gynecologic Cancer, 1996
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Ovarian cancer—New insights into systemic therapy
  European Journal Of Cancer, 1995
• Comparison of the Emetogenic Potential Between Cisplatin and Carboplatin in Combination with Alkylating Agents
  Acta Oncologica, 1994
• Long-term results of a randomized trial comparing cisplatin with cisplatin and cyclophosphamide with cisplatin, cyclophosphamide, and adriamycin in advanced ovarian cancer
  Gynecologic Oncology, 1992
• Long-term survival in ovarian cancer
  European Journal of Cancer and Clinical Oncology, 1991
• Cyclophosphamide-Cisplatin Versus Cyclophosphamide-Carboplatin in Stage III-IV Ovarian Carcinoma: A Comparison of Equally Myelosuppressive Regimens
  JNCI Journal of the National Cancer Institute, 1989
• A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinoma
  Gynecologic Oncology, 1987